SBP瀬戸内乳腺事業包括的支援機構

最新情報

最新情報

    最新の論文を要約し、コメントをつけて掲載しています。
    是非ダウンロードしてご覧ください。
最新資料DL

基礎・疫学

ファイル名をクリックしてダウンロードして下さい。

タイトル ファイル名 日付 備考
基礎・疫学001:Sequence analysis of mutations and translocations across breast cancer subtypes. kiso_ekigaku_001.docx 12/10/18 18.5kb
基礎・疫学002:Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98. kiso_ekigaku_002.doc 13/07/17 34.5kb
基礎・疫学003:Factors predicting late recurrence for estrogen receptor-positive breast cancer. kiso_ekigaku_003.docx 14/01/15 19.8kb
基礎・疫学004:Activating ESR1 mutations in hormone-resistant metastatic breast cancer. kiso_ekigaku_004.docx 14/05/16 53.7kb
基礎・疫学005:PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (her2) therapy in primary HER2-overexpressing breast cancer. kiso_ekigaku_005.docx 14/12/25 16.3kb
基礎・疫学006:Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199. kiso_ekigaku_006.docx 15/06/05 24.4kb
基礎・疫学007:Clinicopathological characteristics of breast cancer and trends in the management of breast cancer patients in Japan: Based on the Breast Cancer Registry of the Japanese Breast Cancer Society between 2004 and 2011 kiso_ekigaku_007.docx 16/02/01 17.1kb
基礎・疫学008:The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. kiso_ekigaku_008.docx 16/08/16 19.8kb
基礎・疫学009:Plasma ESR1 Mutations and the Treatment of Estrogen Receptor–Positive Advanced Breast Cancer. kiso_ekigaku_009.docx 17/03/27 26.1kb

臨床試験

ファイル名をクリックしてダウンロードして下さい。

タイトル ファイル名 日付 備考
臨床試験001:Long-term eff ects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial rinsyoushiken_001.docx 13/02/11 20.4KB
臨床試験002:Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343 rinsyoushiken_002.doc 13/07/17 33.0KB
臨床試験003:Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study rinsyoushiken_003.docx 14/01/22 20.1KB
臨床試験004:Trastuzumab Emtansine for HER2-Positive Advanced  Breast Cancer. rinsyoushiken_004.docx 14/01/22 24.6KB
臨床試験005:Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study. rinsyoushiken_005.doc 14/02/25 19.5KB
臨床試験006:Eff ect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials rinsyoushiken_006.doc 14/07/03 36.0KB
臨床試験007:Trastuzumab emtansine versus treatment of physician’s choice for pretreated HER2-positive advanced breast cancer (TH3RESA) : a randomised, open-label, phase 3 trial rinsyoushiken_007.docx 14/09/17 18.0KB
臨床試験008:Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer rinsyoushiken_008.docx 15/01/28 52.7KB
臨床試験009:Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy rinsyoushiken_009.docx 15/05/07 20.3KB
臨床試験010:Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer rinsyoushiken_010.docx 15/09/24 26.0KB
臨床試験011:Efficacy of Adjuvant Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer and Tumors ≤ 2 cm: A Meta-Analysis of the Randomized Trastuzumab Trials rinsyoushiken_011.docx 15/09/24 30.0KB
臨床試験012:Prospective Validation of a 21-Gene Expression Assay in Breast Cancer rinsyoushiken_012.docx 16/06/15 27.0KB
臨床試験013:Olanzapine for the Prevention of chemotherapy-Induced Nausea and Vomiting rinsyoushiken_013.docx 16/09/06 18.6KB
臨床試験014:Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer rinsyoushiken_014.docx 16/11/07 16.1KB
臨床試験015:MARIANNE試験について rinsyoushiken_015.docx 17/01/16 16.3KB
rinsyou_015edirorial.docx 16.9KB
rinsyou_015negative.docx 12.4KB
臨床試験016:PALOMAstudy rinsyoushiken_016.docx 17/08/05 20.1KB
臨床試験017:Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype rinsyoushiken_017.docx 17/08/05 37.3KB

検診

ファイル名をクリックしてダウンロードして下さい。

タイトル ファイル名 日付 備考
検診001:Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomized controlled trial kenshin_001.docx 15/12/22 34KB
日本乳癌検診学会最新情報・感想記 nyugankenshin201612.docx 16/12/12 16KB

SBP

瀬戸内乳腺事業包括的支援事業

Copyright (c) SBP. All Right Reserved.